Urinary bile acid excretion was studied by gas chromatography/mass spectrometry in 4 infants with intrahepatic cholestasis and pruritus, aged 4-20 months, before and after administration of P (10 mgl kglday). Serum levels o f bilirubin and bile acids decreased but t h e activites o f y-glutamyltransferase (S-GT) and alkaline phosphatase s (S-ALP) mainly increased. Most infants increased their total bile acid excretion in urine by 4-fold. The percentage polyhydroxylated bile acids increased much more: before treatment tetra-OH-bile acids ranging from 0 t o 7.6% (mean 2.4%) and after 3 t o 100 weeks of treatment from 4.8 to 25.5 % (mean 17.2%) o f total urinary bile acids (p<O.OOl). The predominant bile acids after treatment were cholic acid, 1,3,7,12 and 3,6, 7,12 tetra-OH-5 0-cholanoic acids and hyocholic acid. Excretion o f chenodeoxycholic acid w a s mainly unchanged. The relative amounts of sulphated bile acids decreased in all cases after treatment, before being 52-68% (mean 60%) and after 13-56% (mean 33%).
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Although serum bilirubin levels decreased and polyhydroxylated bile acid excretion increased after P treatment, t h e increase o f S-GT and S-ALP and t h e increased urinary excretion of cholic acid end total bile acids suggest more severe cholestasis. Our results indicate that further studies are necessary to show if P i s beneficial in cholestatic disease i n infancy. It might, on t h e contrary be a hazard in early infancy,and at presentaroutine administration t o cholestatic infants is not recomnended. 
S-ADENOSYLMETHIONINE ISAMe) REVERSES TOTAL PARENTERAL

HEPATITIS ICBH).
A. Vegnente, C. Pignata, V. Nuzzo, G. Monaco, V. Dl Costanzo Dept. of Pediatrics, 2nd Schwl of Iledlclne, Naples, Italy It 1s known that children with CBH have low levels of T lymphocytes espressing IL-2 receptors and that in adults affected by CBH there is a reduced production of IL-2. The aim of this study was to evaluate the production of IL-2 by lymphocytes following stimulation with phytoaemoagglutinin I M ) in a group of children wlth CBII. Nine children (6 males) affected by CBH were investigated.The mean age was 9y-6m, and the mean duration of the disease was 3y-2..
The aspartate-amino transferase IAST) levels varied between 2 and 8 times the normal values (NV), wlth the majority having 3 times above the upper normal limit. All subjects were HBsAg posltlve ("+") . 6 children were HBeAg "+", 3 of whom vere also anti-HDV "+", and 3 were HBcAb "t", of whom 2 had anti-HDV antibodies. The serum levels of IgG were i:lcreased in 8 patients. The liver biopsy, performed in 5 children, showed histologlca1,features of chronic active hepatitis in 3 and cirrhosis in 2. 8 age and sex matched healthy children were studied as controls. IL-2 production was obtained by peripheral blood mononuclear cells stimulated with PHA (lmcglml) after monocytes were removed by plastic adhesion. The activity of IL-2-containing supernatants was tested using PIN-induced blast cells by H3-thymidine incorporation. Levels of IL-2 are expressed as unlts/ml according to Saxena et al.11) The mean value (34.78 Ulml) was significantly lover in CBH children when compared to controls 1105.37 Ulml; Lp<0.05). Thls preliminary study indicates that IL-2 production is impaired in CBH children. Thls could explain the imunological alternations seen in CBH patients. A total of 24 chilCen (2-12 years) Mere randolly allocated In tuo groups: control (~1 2 1 and treatpent ~n=l?), ubo received 10 U l of rlFNv2A lhferonlllc bcdy surface. 1.n.. tbllCe weekly durlng 3 Mntbs, All of then ha6 a blstolcqical dlagnosls of C M and were BBsAg. HBeAg and HBV-MA posltlve for at least 6 MIIlhS before entry Into the study.
The treatment was uell tolerated a d all children colpleted tbe study. At tbe end of tbe treatment period. 3 w t of the 12 (33w treated patients, becane HW-DNA negative, Another treated patlent lost HBV-DIIA at tbe 6tb wnth and a total of 4 patlents renalned Ilke that untll the l2tb mntb of follow-up. Hone of the controls lost HBV-OW), durlng tbe flrst SIX aotths of the study but 2 patlents belonging to tbls proup becane HBV-DWA negative at the 9th sonth and dnotber 2 at the 12tb lontb. A total of 4 treated patlents and 3 controls uere HBeRg negatlve at tbe 12th month of follou-up. A w k e d decrease In ALT levels, along tke four respoder children s s observed, In contrast no variations a~w non-responden uere dMected.
In sunnary. r1PN-a therapy In CM-HBV Infection In chlldren Iswell tolerated. In additlcn, an antlvlral effett was observed. Our prevlous results suggest that prolonged tberdpy (6 Ponths, thrlce ueexly) could be useful In the treatnent of cblldren ulth chronic 8BV !tfect ion
